EverPoint Asset Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$352K Buy
+60,000
New +$352K 0.01% 347
2015
Q2
Sell
-250,000
Closed -$3.18M 595
2015
Q1
$3.18M Buy
+250,000
New +$3.18M 0.06% 325